Hun-Sik Wang
Algemeen Directeur bij GL PHARM TECH CORP.
Vermogen: 855 182 $ op 31-05-2024
Profiel
Hun-Sik Wang is currently the Chief Executive Officer and Director at GL Pharm Tech Corp.
Prior to this, he was the Chief Executive Officer at GL PharmTech, Inc. and Co-Chief Executive Officer at Crown Pharm Co., Ltd.
He holds a doctorate degree from Chungnam National University and a graduate degree from Chung-Ang University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GL PHARM TECH CORP.
1.30% | 06-03-2024 | 993 323 ( 1.30% ) | 855 182 $ | 31-05-2024 |
Actieve functies van Hun-Sik Wang
| Bedrijven | Functie | Begin |
|---|---|---|
| GL PHARM TECH CORP. | Algemeen Directeur | 01-08-2002 |
Eerdere bekende functies van Hun-Sik Wang
| Bedrijven | Functie | Einde |
|---|---|---|
Crown Pharm Co., Ltd.
 Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Algemeen Directeur | - |
GL PharmTech, Inc. /Old/
 GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Algemeen Directeur | - |
Opleiding van Hun-Sik Wang
| Chungnam National University | Doctorate Degree |
| Chung-Ang University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
GL PharmTech, Inc. /Old/
GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Health Technology |
| GL Pharm Tech Corp. | |
Crown Pharm Co., Ltd.
Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Health Technology |
